Forus logo
AI/ML
Enterprise SaaS
HealthTech

Forus

AI-powered medication access infrastructure

New York office· 52 roles

CORE INFO

$150M
Total Funding
Series C
Round
2023
Founded
100-220
Team Size
New York City, United States
Headquarters

Forus provides software that handles the administrative work between a clinician prescribing medication and a patient starting treatment, including insurance approvals, appeals, affordability support, pharmacy routing, and patient updates. Healthcare providers and patients use it for free, while the company works with biopharmaceutical and life-sciences companies.

  • Series C funding totaled $150 million at a reported $3 billion valuation, with Bain Capital Ventures leading the round announced September 8, 2026.fiercehealthcare.com
  • Thousands of medical practices and health systems use the platform, according to Forbes.forbes.com
  • Forbes reported annualized revenue above $10 million at year-end 2025 and roughly fivefold growth during 2026, implying a run rate above $50 million at the time of publication.forbes.com

WHY WE WOULD WORK AT FORUS

Make Medicine Reachable

Help turn prescriptions into treatments by removing barriers across prior authorizations, affordability, pharmacy routing, and patient communication. Forus's mission is clear: science should be the only limit to medicine.

Scale a Breakout Company

Join a company founded in 2023 that has raised more than $300 million, reached a reported $3 billion valuation, and expanded to thousands of medical practices and health systems.

Build Real Healthcare AI

Work on AI agents, clinical models, RAG-powered appeals, denial prediction, and EHR integrations that operate across drugs, payers, pharmacies, and all 50 states.

Shape Products with Clinicians

Collaborate directly with clinical intelligence leaders and practicing physicians to build software around real medication-access workflows. Customer examples include DOCS Dermatology, Aspire Allergy & Sinus, and Family Allergy & Asthma.

Own High-Impact Problems

See measurable results from your work, including prior-authorization turnaround reduced to 1.1 days and nursing administrative workload reduced by 70% in a reported customer case.

Grow with Real Ownership

Work in a high-trust, high-autonomy culture built around direct communication, rigorous thinking, and raising the bar. Forus emphasizes meaningful equity alongside the chance to help define a rapidly expanding category.

MARKET AND TRACTION

MARKET POSITION

✦ KEY METRIC
  • Forus supports medication-access workflows across all 50 U.S. states, including pharmacy- and medical-benefit therapies, specialty-pharmacy medications, and buy-and-bill treatments.

  • The platform is used by thousands of medical practices and health systems, with patients reportedly reached in more than 80% of U.S. ZIP codes.
  • KEY METRICS

    ✦ KEY METRIC
  • Forus reports provider adoption growing approximately 10 times year over year for the previous two years.

  • Forbes reported annualized revenue above $10 million at year-end 2025 and an implied run rate above $50 million by May 2026; these figures were company-reported and not independently audited.

  • The company has raised more than $300 million, including a $150 million Series C at a reported $3 billion valuation.
  • NOTABLE CUSTOMERS

    ✦ KEY METRIC
  • Publicly featured healthcare customers include Aspire Allergy & Sinus, Family Allergy & Asthma, MedicoCX, DOCS Dermatology, Virginia Rheumatology Clinic, and Modern Migraine MD.

  • Aspire Allergy & Sinus used Forus across 63 offices, while DOCS Dermatology deployed the platform across a 140-location network.

  • Forus reports relationships with nine of the 15 largest global biopharmaceutical companies, although the companies' names have not been disclosed.
  • GROWTH TACTICS

  • Forus offers its platform free to healthcare providers and patients, using partnerships with biopharmaceutical and life-sciences companies as its apparent monetization model.

  • The company has expanded through provider and health-system adoption, strategic partnerships such as OpenEvidence and the American Gastroenterological Association, and a broader network connecting clinicians, pharmacies, payers, patients, and manufacturers.
  • COMPETITIVE ADVANTAGE

  • Forus combines AI agents, clinical models, payer-specific workflow automation, EHR integrations, pharmacy routing, affordability support, and human-in-the-loop operations in one medication-access platform.

  • Its network is designed to provide visibility from prescription writing through coverage, distribution, and treatment initiation, while supporting all drugs, insurance plans, pharmacies, and care settings.
  • PRODUCT AND TECH

    Medication Access Automation

    AI-powered workflows automate the work between prescription writing and treatment initiation, including benefit verification, enrollment forms, affordability assistance, and patient communication.

    Prior Authorization Intelligence

    AI agents generate and submit payer-specific authorization forms, predict denials, score clinical information, and create appeal letters using large language models and retrieval-augmented generation.

    EHR Record Integration

    Forus connects to electronic health records to extract relevant clinical documentation, while also supporting manually uploaded records when an integration is unavailable.

    Pharmacy Care Coordination

    The platform routes prescriptions to specialty and preferred pharmacies, supports pharmacy calls and renewal tracking, and coordinates buy-and-bill therapies across medical and pharmacy benefits.

    Clinical AI Network

    Clinical models, human-in-the-loop support, and prescription outcome data help Forus coordinate providers, payers, pharmacies, patients, and life-sciences companies across medication-access workflows.

    COMPANY CULTURE

    Values

  • Science should be the only limit to medicine

  • Fight for users and prioritize real-world outcomes

  • Maintain high standards for speed and execution
  • Operating Principles

  • Do the math: reason from first principles

  • Resourceful optimism: assume problems are solvable

  • Spit it out: communicate directly and invite critique

  • Raise the bar through high standards and ownership
  • Work Style

  • High-trust and high-autonomy environment

  • Fast-paced, execution-oriented collaboration

  • Cross-functional teams combining engineering, product, operations, and clinical expertise

  • Clinicians embedded in product development, quality assurance, and model improvement
  • Team Cadence

  • Work closely across product, engineering, clinical intelligence, and life-sciences partnerships

  • Focus on practical healthcare workflows and measurable user outcomes

  • Iterate AI systems using prescription and treatment-access outcomes
  • COMPENSATION SNAPSHOT

    B+
    Comp score vs cohort
    vs. AI/ML · Series C · US
    Based on publicly available compensation ranges from job postings; exact compensation may vary.
    G&An = 5
    $150K – $250Kmedian $200K
    New York
    Marketingn = 3
    $180K – $240Kmedian $210K
    New York
    Operationsn = 8
    $145K – $250Kmedian $198K
    New York
    Product ICn = 3
    $170K – $300Kmedian $235K
    New York
    US-only in v1 · only categories with n > 2 shown · in-person / hybrid / remote treated separately where n ≥ 3

    HIRING SIGNAL

    52
    Open roles on their careers page
    Snapshot via live ATS poll
    —
    Net new roles in the last 90 days
    Available once weekly history accrues
    90-Day VelocityV2 · BACKFILL
    Trend builds weekly as historical rows accrue
    By Function
    Breakdown of open roles
    Data · 3
    GTM · 9
    Design · 3
    G&A · 8
    Product · 3
    Support · 1
    Marketing · 5
    Operations · 10
    Engineering · 10
    Top Locations
    Where hiring is concentrated
    Remote-eligible postings counted separately
    New York office
    52
    SourcesGreenhouseLeverAshbyWorkableSmartRecruitersRipplingRecruiteeFallback · Wellfound, YC Work-at-a-Startup, careers-page scrape

    KEY COMPANY ANNOUNCEMENTS

    Filter
    10 announcements · ranked by importance
    Sep 8, 2026FUNDINGForus Raises $150M Series C to Make Science the Only Limit on Medicine | Forusforus.com
    May 1, 2026FUNDINGForus Raises $160M to Build the Foundation for Modern Medicinefinance.yahoo.com
    May 12, 2026FOUNDER PROFILEBillions In Prescriptions Go Unfilled. This Startup Is Using AI To Fix That.forbes.com
    Jan 1, 2025FOUNDER PROFILESahir Jaggiforbes.com
    Jan 1, 2024FUNDINGDoubling Down on Forusgeneralcatalyst.com
    Aug 24, 2026INTERVIEWSahir Jaggi on Forus: Building…–Pear Healthcare Playbook – Apple Podcastspodcasts.apple.com
    Jun 4, 2026CUSTOMER WINAllergy Prior Authorization Automation | Forus | Forusforus.com
    Jul 9, 2026PRESSForus & AGA Partner to Improve GI Medication Access | Forusforus.com
    Dec 1, 2025CUSTOMER WINGI Prior Authorization Automation | Forusforus.com
    Jan 13, 2026CUSTOMER WINZepbound Prior Authorization for Sleep Apnea | Forusforus.com